Sen P, Knolle F
Neuroimage Clin. 2025; 45:103756.
PMID: 39983553
PMC: 11889563.
DOI: 10.1016/j.nicl.2025.103756.
Nisha Aji K, Lalang N, Ramos-Jimenez C, Rahimian R, Mechawar N, Turecki G
Mol Psychiatry. 2024; .
PMID: 39511452
DOI: 10.1038/s41380-024-02816-x.
Coffman B, Curtis M, Seebold D, Kocsis J, Dani A, Lopez-Caballero F
Psychiatry Res. 2024; 339():116094.
PMID: 39053213
PMC: 11321909.
DOI: 10.1016/j.psychres.2024.116094.
Chen H, Zhou M, Han L, Manoharasetty A, Yu Z, Luo H
Front Psychiatry. 2024; 15:1246986.
PMID: 38525259
PMC: 10957764.
DOI: 10.3389/fpsyt.2024.1246986.
Laricchiuta D, Papi M, Decandia D, Panuccio A, Cutuli D, Peciccia M
Front Cell Neurosci. 2024; 18:1358450.
PMID: 38419655
PMC: 10899480.
DOI: 10.3389/fncel.2024.1358450.
Illness Phase as a Key Assessment and Intervention Window for Psychosis.
Kohler C, Wolf D, Abi-Dargham A, Anticevic A, Cho Y, Fonteneau C
Biol Psychiatry Glob Open Sci. 2023; 3(3):340-350.
PMID: 37519466
PMC: 10382701.
DOI: 10.1016/j.bpsgos.2022.05.009.
Candidate biomarkers in psychiatric disorders: state of the field.
Abi-Dargham A, Moeller S, Ali F, DeLorenzo C, Domschke K, Horga G
World Psychiatry. 2023; 22(2):236-262.
PMID: 37159365
PMC: 10168176.
DOI: 10.1002/wps.21078.
A Meta-Analysis of Neural Correlates of Reward Anticipation in Individuals at Clinical Risk for Schizophrenia.
Zeng J, Yan J, You L, Liao T, Luo Y, Cheng B
Int J Neuropsychopharmacol. 2023; 26(4):280-293.
PMID: 36893068
PMC: 10109154.
DOI: 10.1093/ijnp/pyad009.
Using Nonhuman Primate Models to Reverse-Engineer Prefrontal Circuit Failure Underlying Cognitive Deficits in Schizophrenia.
Chafee M
Curr Top Behav Neurosci. 2023; 63:315-362.
PMID: 36607528
DOI: 10.1007/7854_2022_407.
Microglia sequelae: brain signature of innate immunity in schizophrenia.
Rodrigues-Neves A, Ambrosio A, Gomes C
Transl Psychiatry. 2022; 12(1):493.
PMID: 36443303
PMC: 9705537.
DOI: 10.1038/s41398-022-02197-1.
Dorsal striatial hypoconnectivity predicts antipsychotic medication treatment response in first-episode psychosis and unmedicated patients with schizophrenia.
Nelson E, Kraguljac N, Maximo J, Armstrong W, Lahti A
Brain Behav. 2022; 12(11):e2625.
PMID: 36237115
PMC: 9660417.
DOI: 10.1002/brb3.2625.
The Relationship Between Frontostriatal Connectivity and Striatal Dopamine Function in Schizophrenia: An 18F-DOPA PET and Diffusion Tensor Imaging Study in Treatment Responsive and Resistant Patients.
Shin S, Jung W, McCutcheon R, Veronese M, Beck K, Lee J
Psychiatry Investig. 2022; 19(7):570-579.
PMID: 35903059
PMC: 9334810.
DOI: 10.30773/pi.2022.0033.
The relationship between glutamate, dopamine, and cortical gray matter: A simultaneous PET-MR study.
Rogeau A, Nordio G, Veronese M, Brown K, Nour M, Osugo M
Mol Psychiatry. 2022; 27(8):3493-3500.
PMID: 35546633
PMC: 9708555.
DOI: 10.1038/s41380-022-01596-6.
Frontostriatothalamic effective connectivity and dopaminergic function in the psychosis continuum.
Sabaroedin K, Razi A, Chopra S, Tran N, Pozaruk A, Chen Z
Brain. 2022; 146(1):372-386.
PMID: 35094052
PMC: 9825436.
DOI: 10.1093/brain/awac018.
Integrating trauma, self-disturbances, cognitive biases, and personality into a model for the risk of psychosis: a longitudinal study in a non-clinical sample.
Pionke-Ubych R, Frydecka D, Cechnicki A, Krezolek M, Nelson B, Gaweda L
Eur Arch Psychiatry Clin Neurosci. 2021; 272(6):1073-1085.
PMID: 34859297
PMC: 9388435.
DOI: 10.1007/s00406-021-01355-8.
Neural Correlates of Mentalizing in Individuals With Clinical High Risk for Schizophrenia: ALE Meta-Analysis.
Vucurovic K, Caillies S, Kaladjian A
Front Psychiatry. 2021; 12:634015.
PMID: 33959048
PMC: 8095711.
DOI: 10.3389/fpsyt.2021.634015.
Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia.
Sonnenschein S, Gomes F, Grace A
Front Psychiatry. 2020; 11:613.
PMID: 32719622
PMC: 7350524.
DOI: 10.3389/fpsyt.2020.00613.
The role of dopamine dysregulation and evidence for the transdiagnostic nature of elevated dopamine synthesis in psychosis: a positron emission tomography (PET) study comparing schizophrenia, delusional disorder, and other psychotic disorders.
Cheng P, Chang W, Lo G, Chan K, Lee H, Hui L
Neuropsychopharmacology. 2020; 45(11):1870-1876.
PMID: 32612207
PMC: 7608388.
DOI: 10.1038/s41386-020-0740-x.
Potential Roles of Redox Dysregulation in the Development of Schizophrenia.
Perkins D, Jeffries C, Do K
Biol Psychiatry. 2020; 88(4):326-336.
PMID: 32560962
PMC: 7395886.
DOI: 10.1016/j.biopsych.2020.03.016.
Adolescents at clinical high risk for psychosis show qualitatively altered patterns of activation during rule learning.
Orr J, Lopez J, Imburgio M, Pelletier-Baldelli A, Bernard J, Mittal V
Neuroimage Clin. 2020; 27:102286.
PMID: 32512402
PMC: 7281799.
DOI: 10.1016/j.nicl.2020.102286.